Alterity Therapeutics (ATHE) Assets (2017 - 2018)
Alterity Therapeutics (ATHE) has 2 years of Assets data on record, last reported at $14.2 million in Q2 2018.
- For Q2 2018, Assets fell 25.35% year-over-year to $14.2 million; the TTM value through Jun 2018 reached $14.2 million, changed N/A, while the annual FY2018 figure was $14.2 million, 25.64% down from the prior year.
- Assets reached $14.2 million in Q2 2018 per ATHE's latest filing, down from $19.0 million in the prior quarter.
- Across five years, Assets topped out at $19.0 million in Q2 2017 and bottomed at $14.2 million in Q2 2018.